Associate
Sponsor
Sunday, April 19, 2015| Latest E-book
You are here:
Pharma
#

Pharma

Articles

View all

Revelry in markets as healthy IIP pushes Sensex, Nifty over one-month high

Apr 13, 2015

Revelry in markets as healthy IIP pushes Sensex, Nifty over one-month high

The 50-share NSE Nifty ended above the 8,800-level by rising 53.65 points or 0.61 per cent to 8,834.00 after shuttling between 8,841.65 and 8,762.10 intra-day. #Business #Sensex #Hindalco #Bharti Airtel #nifty #Sun Pharma #IIP #BSE #NSE #BHEL #Areva #MarketClose
Sensex logs best fiscal year gain since 2009-10

Mar 31, 2015

Sensex logs best fiscal year gain since 2009-10

Among 30-share Sensex pack, ONGC dropped by 2.51 percent, Tata Steel 1.72 percent, Hindalco 1.71 percent, BHEL 1.53 percent, HDFC Bank 1.32 percent and M&M 1.06 percent. #Business #Sensex #Reliance Industries #Narendra Modi #Tata Motors #Sun Pharma #GAIL #BSE #Cipla #MarketClose #Dr Reddy's Lab
Sensex edges down in cautious trade, Sun Pharma rises

Mar 25, 2015

Sensex edges down in cautious trade, Sun Pharma rises

Shares have retreated since hitting record highs early this month, as analysts warned about waning momentum and low trading volumes ahead of the end of the fiscal year at the end of March. #Sensex #Larsen & Toubro #nifty #Tata Motors #Sun Pharma #BSE #Ranbaxy #MarketWatch #Ipca Laboratories
Sensex falls for fifth day, down 30 points at over nine-week low

Mar 24, 2015

Sensex falls for fifth day, down 30 points at over nine-week low

Traders said volatility was mainly due to rolling over of positions in the futures and options segment from the near month March to April series. March derivative contracts will expire on Thursday. #Sensex #Bharti Airtel #wipro #Sun Pharma #HDFC #BSE #RIL #MarketClose #Foreign Portfolio Investors #Dr Reddy's Lab #Domestic institutional investors #Asian Development Bank's

BLOG POSTS

View all

It's not just Ranbaxy, our health care regulators have failed us too

May 23, 2013

It's not just Ranbaxy, our health care regulators have failed us too

The Ranbaxy saga of fraud and greed goes beyond that. In India, it shows how our regulators too have failed us. #TheLongView #Health #Drugs #Ranbaxy #Healthcare #Pharma
Why a global fight against cancer is a good idea

Apr 10, 2013

Why a global fight against cancer is a good idea

In a substantive paper published today in the journal Nature Reviews, a group of authors from Singapore, the USA and Brazil evaluate the cost of cancer medication in low and middle income countries. #WhyNow #Cancer #Healthcare #Diabetes #Novartis #glivec #Merck #Dabur Pharma